Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 149.90B | 137.59B | 137.48B | 121.84B | 187.70B |
Gross Profit | 14.66B | 13.37B | 13.16B | 12.51B | 11.70B |
EBITDA | 6.78B | 5.30B | 4.26B | 4.16B | 3.75B |
Net Income | 2.90B | 2.13B | 1.39B | 1.15B | 1.26B |
Balance Sheet | |||||
Total Assets | 74.76B | 78.42B | 73.29B | 71.61B | 68.86B |
Cash, Cash Equivalents and Short-Term Investments | 5.53B | 7.11B | 8.36B | 7.54B | 9.59B |
Total Debt | 19.24B | 24.46B | 28.03B | 24.74B | 24.61B |
Total Liabilities | 40.95B | 47.42B | 47.17B | 42.58B | 41.61B |
Stockholders Equity | 32.04B | 29.32B | 24.47B | 24.43B | 23.14B |
Cash Flow | |||||
Free Cash Flow | 3.41B | 2.18B | 2.36B | -2.67B | 3.99B |
Operating Cash Flow | 3.92B | 3.59B | 3.34B | -814.00M | 5.42B |
Investing Cash Flow | 397.00M | -637.00M | -666.00M | -795.00M | -1.83B |
Financing Cash Flow | -5.89B | -4.21B | -1.86B | -453.00M | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥14.76B | 5.44 | 3.01% | 7.29% | 10.64% | ||
80 Outperform | ¥19.48B | 6.64 | 4.03% | 8.07% | -13.57% | ||
74 Outperform | ¥18.41B | 13.04 | 2.18% | 3.22% | 7.14% | ||
69 Neutral | ¥4.52B | 4.16 | 1.78% | 2.56% | 16.26% | ||
63 Neutral | $21.01B | 14.53 | -7.26% | 3.13% | 3.36% | -7.91% | |
60 Neutral | ¥8.12B | 22.92 | 0.99% | 5.89% | 82.20% | ||
52 Neutral | ¥2.69B | 1,228.58 | 0.95% | -0.03% | -97.12% |